￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Safety and efficacy of nivolumab 3 mg/kg as monotherapy in the treatment of advanced or metastatic squamous NSCLC_Canghule

2025-10-19 11:44:20

Check Details
Which patients are suitable for the immunotherapy drug nivolumab?

2025-10-19 11:44:20

Check Details
Has the immune checkpoint inhibitor nivolumab been included in the national medical insurance drug list?

2025-10-19 11:44:20

Check Details
Progression-free survival with alectinib in ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Application of alectinib in ALK-positive locally advanced or metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How much does a box of alectinib cost? Is it covered by medical insurance?

2025-10-19 11:44:20

Check Details
How much will an individual pay out-of-pocket for alectinib after medical insurance reimbursement in 2021?

2025-10-19 11:44:20

Check Details
Can alectinib treat patients who are resistant to ceritinib?

2025-10-19 11:44:20

Check Details
Is Erlotinib Hydrochloride Tablets (Tarceva) the first choice anti-cancer drug for lung cancer?

2025-10-19 11:44:20

Check Details
Safety, efficacy and tolerability of alectinib in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Does alectinib have an effect on patients with lung cancer and brain metastases?

2025-10-19 11:44:20

Check Details
Treatment options for ALK-positive non-small cell lung cancer-Alectinib

2025-10-19 11:44:20

Check Details
Category
相关知识